Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Noya

Showing results (151-160 of 156) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 156 results.
Arquivos Brasileiros De Cardiologia|February 20, 2020
Prognostic Value of NT-proBNP versus Killip Classification in Patients with Acute Coronary SyndromesThiago M B Souza, Antônio Maurício S Cerqueira, Jessica G Suerdieck, et al.
Arquivos Brasileiros De Cardiologia|October 1, 2024
Lack of Anticoagulant Use in Patients with Atrial Fibrillation and Increased Risk of Thromboembolic Events According to Sex: Insights from a Multicentric Brazilian StudyEmiliano Medei, Renata Moll-Bernardes, Martha V T Pinheiro, et al.
Journal of Clinical Medicine|October 14, 2022
Troponin in COVID-19: To Measure or Not to Measure? Insights from a Prospective Cohort StudyRenata Moll-Bernardes, João D Mattos, Eduardo B Schaustz, et al.
International Journal of Obesity (2005)|November 6, 2023
Impact of the immune profiles of hypertensive patients with and without obesity on COVID-19 severityRenata Moll-Bernardes, Juliana R Ferreira, Andréa Silvestre Sousa, et al.
Journal of Clinical Immunology|June 9, 2023
New Insights on the Mechanisms of Myocardial Injury in Hypertensive Patients With COVID-19Renata Moll-Bernardes, Juliana R Ferreira, Eduardo B Schaustz, et al.
JAMA|January 19, 2021
Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical TrialRenato D Lopes, Ariane V S Macedo, Pedro G M de Barros E Silva, et al.
Pageof 16

Showing results (151-160 of 156) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 156 results.
Arquivos Brasileiros De Cardiologia|February 20, 2020
Prognostic Value of NT-proBNP versus Killip Classification in Patients with Acute Coronary SyndromesThiago M B Souza, Antônio Maurício S Cerqueira, Jessica G Suerdieck, et al.
Arquivos Brasileiros De Cardiologia|October 1, 2024
Lack of Anticoagulant Use in Patients with Atrial Fibrillation and Increased Risk of Thromboembolic Events According to Sex: Insights from a Multicentric Brazilian StudyEmiliano Medei, Renata Moll-Bernardes, Martha V T Pinheiro, et al.
Journal of Clinical Medicine|October 14, 2022
Troponin in COVID-19: To Measure or Not to Measure? Insights from a Prospective Cohort StudyRenata Moll-Bernardes, João D Mattos, Eduardo B Schaustz, et al.
International Journal of Obesity (2005)|November 6, 2023
Impact of the immune profiles of hypertensive patients with and without obesity on COVID-19 severityRenata Moll-Bernardes, Juliana R Ferreira, Andréa Silvestre Sousa, et al.
Journal of Clinical Immunology|June 9, 2023
New Insights on the Mechanisms of Myocardial Injury in Hypertensive Patients With COVID-19Renata Moll-Bernardes, Juliana R Ferreira, Eduardo B Schaustz, et al.
JAMA|January 19, 2021
Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical TrialRenato D Lopes, Ariane V S Macedo, Pedro G M de Barros E Silva, et al.
Pageof 16